Bridging the Gap: How Technology and Patient Experience Can Improve Clinical Trial Timelines



Webinar Date/Time: Thu, Mar 28, 2024 12:00 PM EDT

As technology drives rapid transformation, the potential for innovation and improved efficiency in clinical research has never been more promising. As the industry advances and delivers innovative technologies, it is imperative to continually listen to patients—delivering what they want and need—to enhance the clinical trial experience.

Register Free:

Event overview

Are you struggling to meet your clinical trial timelines? A recent McKinsey report states that, “Up to 80 percent of clinical trials fail to finish on time.” Study teams grapple with start-up, protocol amendment implementation, and providing participants of varying demographics with easy-to-use technologies.

As technology drives rapid transformation, the potential for innovation and improved efficiency in clinical research has never been more promising. As we advance, delivering innovative technologies, we must continually listen to patients, delivering what they want and need—to enhance the clinical trial experience.

In this all-new webinar, a panel of experts will unveil new research findings, sharing insights into what patients want in clinical trial technology and how industry leaders are leveraging innovation to enhance outcomes. Discover:

  • What drives patient participation and retention from a tech-standpoint
  • New eCOA insights to combat the staggering 30% dropout rate among clinical trial participants
  • And, insights on emerging wearables and how they are transforming data collection across therapeutic areas

Who Should Attend:

  • Clinical Ops and Development Teams
  • Patient Engagement Teams
  • Therapeutic Area Leads
  • Procurement
  • Med Affairs
  • IT and Clinical IT


Drew Bustos
Chief Marketing Officer

Drew stands at the forefront of innovation and design thinking as he directs Global Marketing at YPrime with an unyielding commitment to technological advancement. His strategic vision and leadership have been instrumental in pioneering patient-centric technology solutions in the life sciences sector. Drew’s approach is not only strategic but also analytical and data-driven, resulting in a proven track record of substantial growth and market expansion.

Otis Johnson, PhD, MPA
Principal Consultant
Trial Equity

Otis Johnson stands out as a leading authority in clinical research and championing diversity within the pharmaceutical industry. His career began with a transformative 13-year tenure at Merck & Co., where he played a critical role in the approval of Singulair for exercise-induced bronchospasm and helped establish the Global Trial Optimization group. His expertise flourished at Syneos Health and ICON, where he spearheaded advancements in clinical development strategies, focusing on feasibility, clinical informatics, and patient recruitment. As a product management executive at Clario, Otis significantly contributed to the growth of the Trial Oversight analytics product line, turning it into a $30 million venture. He also elevated the organization’s ESG ratings in his role as the Chief Diversity, Inclusion, and Sustainability Officer.

Recognized as a PharmaVoice 100 Most Inspiring Industry Leader, a top DE&I Leader by Mogul, and honored with the Healthcare Businesswomen’s Association (HBA) Honorable Mentor Award, Otis's influence extends far beyond his immediate professional circle. In his current role as Co-founder and Principal Consultant of Trial Equity, Otis works to equip clinical research professionals with the knowledge and skills to enroll more representative patient populations into clinical trials to ensure that medicines are safe and effective for all people.

Terry Rehm
Head of Thought Leadership and Public Relations

With a passion for healthcare innovation and patient advocacy, coupled with three decades of communications and marketing successes with technology organizations, Terry presents relevant thought leadership topics in the most consumable ways. She brings her natural abilities of learning, synthesis, and appreciating multiple perspectives to her work as a business communicator. Her efforts have contributed to the brand awareness and, ultimately, company growth of each organization she has supported.

Donna M. Mongiello, RN, BSN
Senior Vice President, eCOA

Donna’s diverse career began in healthcare as a registered nurse and evolved to focus on technologies that support patients in clinical research. Donna has published articles in trade journals and presented at pharmaceutical industry conferences on topics including patient centricity, improving enrollment success, eCOA, BYOD, and more. With over 18 years in the clinical trials space, Donna currently serves as Senior Vice President, Strategic Solutions at YPrime, where she is responsible for developing and growing strategic partnerships. Donna earned her Bachelor of Science degree in nursing from Thomas Jefferson University.

Register Free:

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.